Status:
UNKNOWN
Primary Patency in Pediatric Patients With Hemodialysis Access
Lead Sponsor:
Alaa Gameil Abd El-salam Hussien
Collaborating Sponsors:
Assiut University
Conditions:
The Aim of This Study is to Follow up Short Term "3-6 Months"& Mid Term" 6-12months "Outcomes of Vascular Access" Native and Synthetic "in ESRD Pediatrics
Eligibility:
All Genders
6-18 years
Brief Summary
Vascular access in the pediatric hemodialysis patients is a challenging,but necessary. It requires proper advance planning to assure that the best permanent access is placeds long life span. It is imp...
Detailed Description
Recent data indicate that the incidence of end stage renal disease (ESRD) in pediatrics has increased over the past two decades\[1\]. Hemodialysis continues to be the most frequently utilized modality...
Eligibility Criteria
Inclusion
- ) Ages :6-18 2) gender: All 3) Children on regular dialysis 4)children with duplex criteria including: vein \>2mm artery\>1mm patent , respirophasic central venous system 5) children's parents compliance to follow-up.
Exclusion
- 1)Children with ESRD contraindicated for vascular intervention including: Children with resistance hyper-tention Children with medical history of bleeding tendency Children with hyper-coagulable state 2)children with duplex criteria including: vein fibrotic "\<2mm" artery\<1mm occluded central veins 3)Children's parents not compliance to follow up
- \-
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 28 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06034717
Start Date
October 1 2022
End Date
September 28 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit university hospital
Asyut, Egypt